FOLD Q4 2019 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$55M+69.4% YoY

Gross Profit

$48M87.4% margin

Operating Income

-$89M-161.0% margin

Net Income

-$90M-162.3% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

+13.4%

Cash Flow

Operating Cash Flow

-$58M

Free Cash Flow

-$69M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$850M

Total Liabilities

$374M

Stockholders' Equity

$476M

Cash & Equivalents

$143M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$55M	$33M	+69.4%
Gross Profit	$48M	$28M	+70.8%
Operating Income	-$89M	-$69M	-28.1%
Net Income	-$90M	-$78M	-14.9%

Geographic Segments

Non-US

$39M71%

UNITED STATES

$16M29%